product Name：()-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
  • Bupivacaine [INN:BAN]; Bupivacaine; (+-)-Bupivacaine; 1-Butyl-2',6'-pipecoloxylidide; AH 250; Anekain; Bupivacaina; Bupivacaina [INN-Spanish]; Bupivacainum; Bupivacainum [INN-Latin]; DL-Bupivacaine; UNII-Y8335394RO; Win 11318; dl-1-Butyl-2',6'-pipecoloxylidide; (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; 2',6'-Pipecoloxylidide, 1-butyl-; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-; Bupivacaine (base and/or unspecified salts); 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; 3-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
  • 2180-92-9;38396-39-3
  • 218-553-3;253-911-2
  • C18H28N2O
  • 288.432
  • InChI=1/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)
  • ()-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 2180-92-9;38396-39-3